Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53
Min Yu(University of Pittsburgh), Olivera J. Finn(University of Pittsburgh), Qimin Zhan(Peking University)
Cited by 72
Related Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
Cancer vaccines: between the idea and the reality
|Nature reviews. Immunology|2003|633
GADD45 induction of a G <sub>2</sub> /M cell cycle checkpoint
|Proceedings of the National Academy of Sciences|1999|621
Genomic instability in Gadd45a-deficient mice
|Nature Genetics|1999|517